Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Diphenhydramine × Other × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 3 Thoracic 2 Other hematologic neoplasm 2 Other solid neoplasm 1 Other 1 Myeloid 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1

Conditions

Stomatitis 1 Neoplasms 1 Mucositis 1

Interventions

tegaserod 3 naloxegol 3 Radiotherapy 2 Radiation 2 Lidocaine 2 Cisplatin 2 prucalopride 1 pegfilgrastim 1 oxycodone naloxone combination 1 indole-3-carbinol 1 hydrated silica gel-based toothpaste 1 alvimopan 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Vitamin D 1 Thyrotropin-Releasing Hormone 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sennosides 1 Selenomethionine 1 Phenolphthalein 1 Observation 1 Nutrition Assessment 1 Methods 1 Metformin 1 Magnesium 1 Ketamine 1 Hematologic Tests 1 Granulocyte Colony-Stimulating Factor 1 Fluorouracil 1 Filgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02606994 2019-02-06

TPvsM

Oral Defense, LLC

Phase 2 Terminated

Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡